First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [18F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas.
Fujimoto H, Fujita N, Hamamatsu K, Murakami T, Nakamoto Y, Saga T, Ishimori T, Shimizu Y, Watanabe H, Sano K, Harada N, Nakamura H, Toyoda K, Kimura H, Nakagawa S, Hirai M, Murakami A, Ono M, Togashi K, Saji H, Inagaki N.
Fujimoto H, et al. Among authors: hamamatsu k.
Front Endocrinol (Lausanne). 2021 Aug 19;12:717101. doi: 10.3389/fendo.2021.717101. eCollection 2021.
Front Endocrinol (Lausanne). 2021.
PMID: 34489868
Free PMC article.
Clinical Trial.